CUAMC
China Universal Asset Management Company Portfolio holdings
AUM
$1.06B
This Quarter Return
+22.53%
1 Year Return
+31.81%
3 Year Return
+205.04%
5 Year Return
–
10 Year Return
–
AUM
$295M
AUM Growth
+$295M
(+19%)
Cap. Flow
+$10.2M
Cap. Flow
% of AUM
3.44%
Top 10 Holdings %
Top 10 Hldgs %
32.39%
Holding
456
New
65
Increased
317
Reduced
38
Closed
9
Top Buys
| 1 |
NVIDIA
NVDA
|
$7.81M |
| 2 |
PayPal
PYPL
|
$4.77M |
| 3 |
STAAR Surgical
STAA
|
$3.64M |
| 4 |
Chipotle Mexican Grill
CMG
|
$3.46M |
| 5 |
Microsoft
MSFT
|
$3.33M |
Top Sells
| 1 |
iQIYI
IQ
|
$7.64M |
| 2 |
Pinduoduo
PDD
|
$6.59M |
| 3 |
ON Semiconductor
ON
|
$4.45M |
| 4 |
Apple
AAPL
|
$3.07M |
| 5 |
Rambus
RMBS
|
$2.77M |
Sector Composition
| 1 | Technology | 38.43% |
| 2 | Consumer Discretionary | 23.55% |
| 3 | Healthcare | 18.31% |
| 4 | Communication Services | 8.83% |
| 5 | Financials | 4.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMGN
276
DELISTED
Immunogen Inc
IMGN
| $11.5K | ﹤0.01% |
2,991
+749
| +33% | +$2.88K |
|
277
Enanta Pharmaceuticals
ENTA
$189M
| $11.4K | ﹤0.01% |
283
+72
| +34% | +$2.91K |
|
278
Kura Oncology
KURA
$732M
| $11.3K | ﹤0.01% |
928
+235
| +34% | +$2.87K |
|
279
Old Dominion Freight Line
ODFL
$31.1B
| $11.2K | ﹤0.01% |
+66
| New | +$11.2K |
|
280
Grifois
GRFS
$6.53B
| $11.2K | ﹤0.01% |
1,524
+395
| +35% | +$2.91K |
|
281
Xcel Energy
XEL
$42.8B
| $11.2K | ﹤0.01% |
+166
| New | +$11.2K |
|
|
CBAY
282
DELISTED
Cymabay Therapeutics
CBAY
| $11.2K | ﹤0.01% |
1,282
+422
| +49% | +$3.68K |
|
283
Regenxbio
RGNX
$498M
| $11.1K | ﹤0.01% |
589
+150
| +34% | +$2.84K |
|
|
INBX
284
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $11.1K | ﹤0.01% |
590
+148
| +33% | +$2.79K |
|
285
Warner Bros
WBD
$29.5B
| $11.1K | ﹤0.01% |
+735
| New | +$11.1K |
|
286
Collegium Pharmaceutical
COLL
$1.25B
| $11.1K | ﹤0.01% |
462
+121
| +35% | +$2.9K |
|
287
Copart
CPRT
$46.5B
| $10.8K | ﹤0.01% |
+288
| New | +$10.8K |
|
288
89bio
ETNB
$1.37B
| $10.4K | ﹤0.01% |
685
+212
| +45% | +$3.23K |
|
289
Innoviva
INVA
$1.32B
| $10.4K | ﹤0.01% |
923
+214
| +30% | +$2.41K |
|
290
ImmunityBio
IBRX
$2.24B
| $10.2K | ﹤0.01% |
5,615
+1,548
| +38% | +$2.82K |
|
291
Cogent Biosciences
COGT
$1.83B
| $10.2K | ﹤0.01% |
947
+237
| +33% | +$2.56K |
|
292
Veeva Systems
VEEV
$44.4B
| $10.1K | ﹤0.01% |
55
| – | – |
|
293
Electronic Arts
EA
$42B
| $10K | ﹤0.01% |
+83
| New | +$10K |
|
294
ADMA Biologics
ADMA
$4.03B
| $9.91K | ﹤0.01% |
2,993
+994
| +50% | +$3.29K |
|
295
Theravance Biopharma
TBPH
$691M
| $9.91K | ﹤0.01% |
913
+229
| +33% | +$2.49K |
|
296
Allogene Therapeutics
ALLO
$249M
| $9.67K | ﹤0.01% |
1,958
+493
| +34% | +$2.44K |
|
297
Seres Therapeutics
MCRB
$162M
| $9.57K | ﹤0.01% |
84
+21
| +33% | +$2.39K |
|
298
Cognizant
CTSH
$35.1B
| $9.38K | ﹤0.01% |
+154
| New | +$9.38K |
|
299
ANI Pharmaceuticals
ANIP
$2.06B
| $9.37K | ﹤0.01% |
236
+58
| +33% | +$2.3K |
|
300
Fastenal
FAST
$56.8B
| $9.33K | ﹤0.01% |
+346
| New | +$9.33K |
|